Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients. (Q48038746)

7 February 2018

editorial

0 references

title

Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients. (English)

1 reference

7 February 2018

chronic renal insufficiency

main subject

1 reference

4

1 reference

7 February 2018

author name string

Gunnar H Heine

series ordinal

1

1 reference

7 February 2018

Kyrill S Rogacev

series ordinal

2

1 reference

7 February 2018

Oliver Weingärtner

series ordinal

3

1 reference

7 February 2018

publication date

19 June 2017

1 reference

7 February 2018

published in

Seminars in Dialysis

1 reference

7 February 2018

volume

30

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

page(s)

390-394

1 reference

7 February 2018

LDL cholesterol: controversies and future therapeutic directions

cites work

1 reference

Triglycerides and cardiovascular disease

21 January 2018

1 reference

HDL and cardiovascular disease

21 January 2018

1 reference

Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future

21 January 2018

1 reference

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

21 January 2018

1 reference

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

21 January 2018

1 reference

HDL cholesterol efflux capacity and incident cardiovascular events

21 January 2018

1 reference

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study

21 January 2018

1 reference

Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks

21 January 2018

1 reference

High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans

21 January 2018

1 reference

HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction

21 January 2018

1 reference

Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients

21 January 2018

1 reference

Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology

21 January 2018

1 reference

Inflammation alters HDL composition and function: implications for HDL-raising therapies

21 January 2018

1 reference

Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.

21 January 2018

1 reference

Uremia alters HDL composition and function

21 January 2018

1 reference

Serum amyloid A in uremic HDL promotes inflammation

21 January 2018

1 reference

Dialysis Modalities and HDL Composition and Function

21 January 2018

1 reference

HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype

21 January 2018

1 reference

HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients

21 January 2018

1 reference

HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients

21 January 2018

1 reference

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

21 January 2018

1 reference

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient

21 January 2018

1 reference

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis.

21 January 2018

1 reference

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk

21 January 2018

1 reference

Controversial role of plant sterol esters in the management of hypercholesterolaemia

21 January 2018

1 reference

Kidney function, cholesterol absorption and remnant lipoprotein accumulation in patients with diabetes mellitus.

21 January 2018

1 reference

Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients

21 January 2018

1 reference

Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators

21 January 2018

1 reference

Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis

21 January 2018

1 reference

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

21 January 2018

1 reference

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/SDI.12621

1 reference

7 February 2018

PubMed ID

28628255

1 reference

7 February 2018